SPONSOR
Beijing 302 Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: VaricesLiver CirrhosisMyelodysplastic SyndromesDecompensated CirrhosisHepatocellular CarcinomaHER2-negative Breast Cancer Brain Metastases
NCT06392503
Recruiting
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Varices
NCT07238686 Phase 2
Recruiting
Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
Myelodysplastic Syndromes
NCT05224960 Phase 2
Recruiting
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
Decompensated Cirrhosis
NCT04512833
Recruiting
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
Hepatocellular Carcinoma
NCT06418594 Phase 2
Recruiting
Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
HER2-negative Breast Cancer Brain Metastases